<DOC>
	<DOCNO>NCT01438801</DOCNO>
	<brief_summary>The evaluation standardize diagnostic test predict growth response 1 year trial Growth Hormone ( GH ) treatment ( carried context regular patient care ) non GH deficient short child low serum insulin-like growth factor-1 ( IGF-1 ) .</brief_summary>
	<brief_title>Predictive Value Insulin-like Growth Factor-1 ( IGF-1 ) Generation Test Growth Response Growth Hormone Treatment ( PRED-IGF )</brief_title>
	<detailed_description />
	<mesh_term>Dwarfism</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<criteria>Age 2.0 9.0 year female , 2.0 10.0 yr male . Prepubertal stage ( Tanner 1 breast ( B1 ) female , Tanner 1 genitals ( G1 ) male ) . Bone age &lt; 10 'years ' ( male ) &lt; 9 'years ' ( female ) accord Greulich Pyle . The bone age read pediatric endocrinologist responsible prestudy screen visit . Height SDS &lt; 2.5 ethnically adequate reference . For child Dutch Western European origin 1997 nationwide reference Dutch child use . For child Moroccan Turkish origin , respective reference chart use . For child ethnicity , 1977 North American ( NCHS/WHO ) reference use , chart accept WHO worldwide standard age 5 year . Has history hypersensitivity growth hormone phenol ( conservative add GH NutropinAq ) , drug similar chemical structure . Has abnormal baseline finding , medical condition ( ) laboratory finding , opinion Investigator , might jeopardise subject 's safety decrease chance obtain satisfactory data need achieve objective ( ) study . Has birth weight and/or length 2 SDS Swedish reference chart . Patients exclude due unknown birth weight length . Has know cause short stature , significant concomitant disease likely interfere growth study schedule/objectives , know contraindication GH treatment .</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>10 Years</maximum_age>
	<verification_date>December 2013</verification_date>
</DOC>